Comedo-ductal carcinoma in situ: A paradoxical role for programmed cell death.
Comedo-DCIS is a histologic subtype of preinvasive breast neoplasia that is characterized by prominent apoptotic cell death and has greater malignant potential than other DCIS subtypes. We investigated the mechanisms of apoptosis in comedo-DCIS and its role in conversion of comedo-DCIS to invasive cancer. Clinical comedo-DCIS excisions and the MCF10DCIS.com human breast cancer model which produces lesions resembling comedo-DCIS were analyzed. Apoptotic luminal and myoepithelial cells were identified by TUNEL and reactivity to cleaved PARP antibody and cell death assessed by Western blotting, Mitocapture and immunohistochemical assays. MCF10DCIS.com cells undergo spontaneous apoptosis in vitro, both in monolayers and multicellular spheroids; it is associated with increased mitochondrial membrane permeability, increase in Bax/Bcl-2 ratio and occurs via caspase-9-dependent p53-independent pathway. This suggests that apoptosis is stromal-independent and that the cells are programmed to undergo apoptosis. Immunostaining with cleaved PARP antibody showed that myoepithelial apoptosis occurs before lesions progress to comedo-DCIS in both clinical comedo-DCIS and in vivo MCF10DCIS.com lesions. Intense staining for MMP-2, MMP-3, MMP-9 and MMP-11 was observed in the stroma and epithelia of solid DCIS lesions prior to conversion to comedo-DCIS in clinical and MCF10DCIS.com lesions. Gelatin zymography showed higher MMP-2 levels in lysates and conditioned media of MCF10DCIS. com cells undergoing apoptosis. These data suggest that signals arising from the outside (microenvironmental) and inside (internal genetic alterations) of the duct act in concert to trigger apoptosis of myoepithelial and luminal epithelial cells. Our findings implicate spontaneous apoptosis in both the etiology and progression of comedo-DCIS. It is possible that spontaneous apoptosis facilitates elimination of cells thus permitting expansion and malignant transformation of cancer cells that are resistant to spontaneous apoptosis.
Shekhar
Malathy P V
MP
Breast Cancer Program, Karmanos Cancer Institute, Department of Pathology, Wayne State University, Detroit, Michigan, USA. shekharm@karmanos.org
Tait
Larry
L
Pauley
Robert J
RJ
Wu
Gen Sheng
GS
Santner
Steven J
SJ
Nangia-Makker
Pratima
P
Shekhar
Varun
V
Nassar
Hind
H
Visscher
Daniel W
DW
Heppner
Gloria H
GH
Miller
Fred R
FR
D000818:Animals; D017209:Apoptosis; D001943:Breast Neoplasms / Q000473:pathology*; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000473:pathology*; D045744:Cell Line, Tumor; D004848:Epithelium / Q000473:pathology; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D007700:Kinetics; D008327:Mammography / Q000379:methods; D051379:Mice; D011065:Poly(ADP-ribose) Polymerases / Q000378:metabolism
D011065:Poly(ADP-ribose) Polymerases
Br J Cancer. 1998 Sep;78(6):788-94
9743302
Eur J Cancer. 1990;26(9):956-9
2177615
Mol Cell. 2003 Mar;11(3):577-90
12667443
J Biol Chem. 2002 Feb 8;277(6):4351-60
11733517
Cancer Res. 2000 Jan 15;60(2):439-49
10667599
Pathol Int. 2003 Jul;53(7):422-8
12828606
Cancer. 1996 May 1;77(9):1831-5
8646681
Ultrastruct Pathol. 2000 May-Jun;24(3):135-44
10914424
Genes Dev. 2001 Nov 15;15(22):2922-33
11711427
J Mammary Gland Biol Neoplasia. 1998 Apr;3(2):177-89
10819526
Clin Cancer Res. 2000 Dec;6(12):4823-30
11156241
Microsc Res Tech. 2002 Oct 15;59(2):92-101
12373719
Cell Biol Toxicol. 1998 Mar;14(2):121-32
9553723
J Natl Cancer Inst. 2004 Jun 16;96(12):906-20
15199110
J Cell Biochem Suppl. 1993;17G:144-52
8007693
JAMA. 1996 Mar 27;275(12):913-8
8598618
J Mammary Gland Biol Neoplasia. 2007 Mar;12(1):15-23
17323120
J Natl Cancer Inst. 2000 Jul 19;92(14):1185-6
10904098
Breast Cancer Res. 2003;5(6):R231-41
14580259
Appl Immunohistochem Mol Morphol. 2005 Mar;13(1):30-7
15722791
Semin Cell Dev Biol. 2000 Jun;11(3):191-201
10906276
Int J Cancer. 2007 May 15;120(10):2127-34
17266026
J Biol Chem. 1998 Dec 11;273(50):33533-9
9837934
Breast Cancer Res Treat. 1986;7(3):171-80
3022849
Int J Oncol. 1996 Aug;9(2):263-7
21541510
Cancer Cell. 2008 May;13(5):394-406
18455123
Exp Cell Res. 2004 Dec 10;301(2):103-18
15530847
Cancer Res. 2002 Apr 1;62(7):2115-24
11929833
J Biol Chem. 2003 May 9;278(19):17408-20
12611882
J Theor Biol. 2005 Feb 21;232(4):523-43
15588633
J Cell Physiol. 2002 Aug;192(2):131-7
12115719
Leukemia. 2000 Sep;14(9):1695-703
10995018
Cell Death Differ. 2003 Oct;10(10):1188-203
14502242
N Engl J Med. 1988 Nov 10;319(19):1239-45
2903446
Am J Clin Pathol. 2007 Jul;128(1):86-91
17580274
Oncol Rep. 2000 May-Jun;7(3):473-8
10767354
CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66
17237035
Semin Cancer Biol. 2000 Dec;10(6):415-33
11170864